User Fee Management System Part Of CDER Plans To Enhance IT Capabilities
This article was originally published in The Pink Sheet Daily
Executive Summary
The need to assimilate biosimilar and generic drug user fee programs and a quest for greater efficiency are major drivers of the center’s proposed $88.9 million spending plan on information technology systems in fiscal year 2014.